GLYX-13, a NMDA Receptor Glycine-Site Functional Partial Agonist, Induces Antidepressant-Like Effects Without Ketamine-Like Side Effects

Recent human clinical studies with the NMDA receptor (NMDAR) antagonist ketamine have revealed profound and long-lasting antidepressant effects with rapid onset in several clinical trials, but antidepressant effects were preceded by dissociative side effects. Here we show that GLYX-13, a novel NMDAR...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Burgdorf, Jeffrey, Zhang, Xiao-lei, Nicholson, Katherine L, Balster, Robert L, David Leander, J, Stanton, Patric K, Gross, Amanda L, Kroes, Roger A, Moskal, Joseph R
Formato: Artigo
Lenguaje:Inglês
Publicado: Nature Publishing Group 2013
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3671991/
https://ncbi.nlm.nih.gov/pubmed/23303054
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/npp.2012.246
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares